Biotechnology and Life Sciences

Whichever area of the biotechnology and life sciences spectrum you occupy, we have the technical expertise and experience to help you to build and utilise your intellectual property. J A Kemp has one of the greatest concentrations of biotechnology and life sciences patent expertise in Europe which means that we excel at tailoring our services to your needs. With over forty European Patent Attorneys working predominantly on biotechnology subject matter, we represent clients in areas as diverse as Antibodies and Biologics, Cell and Gene Therapy, Gene Editing and Engineering, Immunology and Immunotherapy, Microbiology and the Microbiome, Plant Science and Crop Science, RNA/Oligonucleotide technology, Synthetic and Structural biology, and Vaccines and Virology.

For many clients within the life sciences field our work crosses over into pharmaceuticals, or into specialised areas requiring complementary technical skills such as Medical devices, Bioinformatics and Computational Biology, or Diagnostics and Personalised medicine. Our diverse technical backgrounds, with many relevant PhDs, enable us to handle any technology confidently and efficiently. Our work is, by definition, at the cutting edge of science and we routinely work on inventions originating in prestigious universities and commercialised by their technology transfer arms or other research organisations. We also work with many start-ups, spin-out and scale-up businesses, helping them to design and build their patent portfolios as they grow. At the other end of the spectrum, we assist large multinational companies and law firms around the world.

We have particular strength in handling oppositions and appeals at the European Patent Office (EPO) relating to biotechnology and life sciences subject matter, often in multi-party cases, with our Partners having experience in handling high profile cases. We also have the technical expertise to handle and support life sciences and biotechnology cases in the courts in the UK and elsewhere, including the new Unitary Patent Court. We additionally have a dedicated team that specialises in handling Supplementary Protection Certificates (SPCs) for biological pharmaceutical products. Our team helps to maintain protection for these ground-breaking treatments at critical stages in their development, such as following marketing authorisation. Our aim is to meet your needs in the most effective way, using our depth of knowledge to build your intellectual property.